Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115404249A reveals a novel enzymatic route for (S)-nicotine intermediates. Discover cost-effective biocatalysis solutions for scalable pharmaceutical manufacturing.
Novel synthetic route for Edoxaban intermediates avoids sodium azide. Enhances safety and yield for pharmaceutical manufacturing supply chains.
Patent CN111423391A reveals a cost-effective fluorination route for florfenicol intermediates using tetrafluoroethylene, offering significant supply chain advantages.
Patent CN103073570B reveals a trialkyltin complex route for high-purity Moxifloxacin intermediates, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN102477016B reveals asymmetric synthesis for Tapentadol intermediates. Achieve high chiral purity and cost reduction in pharmaceutical manufacturing.
Patent CN105037318B reveals a novel catalytic method for fludioxonil intermediates, offering superior yield, purity, and scalable supply chain solutions for agrochemical manufacturing.
Patent CN101948404B reveals a greener route for Ioxilan intermediates. Discover cost reduction in API manufacturing and high-purity production strategies.
Patent CN106748888B reveals a safer route for sitagliptin intermediates. Reduces explosive risks and costs for reliable pharmaceutical intermediate suppliers.
Patent CN102180862B details a novel Blaise reaction route for Rosuvastatin intermediates, offering high purity, simplified processing, and significant cost reduction potential.
Novel one-step oxidation method for flomoxef intermediate 1 using SeO2. High purity >98%, mild conditions, cost-effective alternative to chlorination.
Patent CN109438538A details a clean 4-AD route for Stanozolol intermediates offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN106699605B offers a safe methylation method for lacosamide intermediates ensuring high purity and scalable production for reliable pharmaceutical supply chains.
Patent CN103145698B reveals high-purity Rivaroxaban intermediate synthesis. Offers cost reduction and supply reliability for pharmaceutical manufacturing.
Novel patent CN115028596B enables mild condition synthesis of topramezone intermediate ensuring high purity and supply chain stability for global agrochemical manufacturing.
Patent CN104592213A reveals a high-yield route for Olmesartan intermediates, offering cost reduction and supply chain reliability for global API manufacturers.
Patent CN116606259B reveals a high-yield three-step route for Sha Mizhu intermediates. This method reduces pollution and enhances supply chain stability for veterinary drug manufacturers.
Patent CN116606259B reveals a high-yield triazine-dione synthesis. Discover cost reduction in veterinary chemical manufacturing and scalable supply solutions.
Patent CN116003384A reveals a novel synthetic route for dabigatran intermediates featuring early-stage cyclization and NHPI oxidation for superior yield and purity.
Patent CN114516877B reveals safer route for PARP inhibitor intermediate with high purity and reduced safety risks for supply chain.
Patent CN1126732C reveals high-yield esterification technology. Reduces toxic solvents significantly. Enhances supply chain reliability for global pharmaceutical intermediates manufacturing.